Process development

At Magle Chemoswed we understand the risk and complexity around the development of a pharmaceutical candidate. Our right first-time philosophy has been tested and proven over numerous projects. We aim to help our customers win with their chosen candidate. Our expertise covers early screening, risk assessments, process development, formulation, and production for clinical trials, tox testing, pre-clinical testing all the way to validation and commercial supply. From early development to full GMP you can count on us.

Organic chemistry

We provide a full review and development planning service, including milestones for early synthesis testing and feasibility standards. We specialise in optimizing the discovery – development interface and assist on planning for phase dependent development plans.

GMP clinical trial material

Our clinical trial manufacturing services are produced in our cGMP compliant facilities supporting investigational medicinal product (IMP) or investigational new drugs (IND) for clinical trials around the world.

One-stop shop

We offer our customers a fully integrated services including with raw material sourcing, supplier approvals and raw material characterisation, formulation development, pilot batch manufacturing, scale-up, pilot batch manufacturing, cleaning method development and full GMP validation and full-scale manufacturing for commercial support.

Documentation and quality

Our development team operate on a risk-based approach with full compliance to GMP requirements, this includes supporting projects with documentation and reports that will be used to support regulatory filings.

Talk to one of our specialists

Ellen Sölver
Ellen has a Master in Chemistry and has worked as a Research and Development Chemist within Magle Chemoswed since 2000.


Magle Chemoswed AB

Agneslundsvägen 27
212 15 Malmö, Sweden
+46 (0)40 38 33 00

Magle Chemoswed and Logos are registered trademarks of Magle Chemoswed.